SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech informs about outcome of postal ballot

20 Mar 2026 Evaluate
Windlas Biotech has informed that this is further to letter dated February 16, 2026, submitting the Postal Ballot Notice ('Notice') dated February 5, 2026, for seeking approval of the Members of the Company by way of Special Resolution(s) for approving the re-appointment of Ashok Kumar Windlass (DIN: 00011451) as Whole-time Director with effect from May 3, 2026, Vivek Dhariwal (DIN: 02826679) as Independent Director with effect from May 6, 2026 and Gaurav Gulati (DIN: 02308392) as Independent Directors with effect from May 6, 2026. Pursuant to the provisions of Section 110 of the Companies Act, 2013, read with related Rules, as amended, the Company conducted the postal ballot by remote e-voting process as set out in the Notice. The remote e-voting process was concluded on Thursday, i.e., March 19, 2026 at 5.00 pm (IST), post which the Scrutinizer has submitted his report on the results of the Postal Ballot. Based on the report of Scrutinizer, the members of the Company have duly passed the above-mentioned Resolution(s) with requisite majority. Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), they are enclosing the details of the voting results (Annexure I) and the Report of the Scrutinizer (Annexure II). The voting results and the Report of the Scrutinizer are being made available on the website of the Company www.windlas.com and on website of MUFG Intime India at www.in.mpms.mufg.com.

The above information is a part of company’s filings submitted to BSE.

Windlas Biotech Share Price

820.55 -36.30 (-4.24%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×